Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with...
WASHINGTON (dpa-AFX) - Yeast bloodstream infections, which are caused by
Candida species, are a type of fungal infection, and if untreated, can result in
serious medical complications. People who have a weak immune system, or are
Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New,
Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia
DGAP-News: Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals Receives FDA Approval of Ferric...
Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.